Gephyrin Neurological Autoimmunity.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 42307210.
- Also identified by DOI 10.1002/ana.78278.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gephyrin is a postsynaptic scaffold protein essential for inhibitory neurotransmission. Gephyrin-immunoglobulin G (IgG) was reported, decades ago, in a single case of paraneoplastic stiff-person-like syndrome, but its broader clinical relevance remains unknown. While investigating unclassified synaptic IgGs mimicking amphiphysin-IgG, we identified gephyrin-IgG in 3 patients using human protein microarray. Gephyrin specificity was confirmed using confocal tissue-based immunofluorescence assay, cell-based assay, and Western blot. The 3 patients, all female, had: encephalitis (2) and myeloneuropathy and breast cancer (1). All had inflammatory cerebrospinal fluid and abnormal magnetic resonance imaging, and improved following immunotherapy. Gephyrin-IgG is associated with a treatable autoimmune neurological disease, sometimes paraneoplastic. ANN NEUROL 2026.